Literature DB >> 20492396

Asymptomatic uterine artery pseudoaneurysm after cesarean section.

Tomoyuki Kuwata1, Shigeki Matsubara, Yuka Kaneko, Akio Izumi, Manabu Nakata, Mitsuaki Suzuki.   

Abstract

Uterine artery pseudoaneurysm is a rare but important complication of cesarean section (CS). If treated inadequately, it may cause profuse life-threatening postpartum hemorrhage. We report an asymptomatic postpartum woman with uterine artery pseudoaneurysm after CS. We also provide a review of published reports of pseudoaneurysm after CS. A 31-year-old Japanese woman underwent CS, in which the uterine incision was extended laterally. Routine postoperative evaluation with vaginal ultrasound on postpartum day 6 revealed a parauterine mass with a maximum diameter of 49 mm with swirling flow. Selective angiography confirmed this mass as a uterine artery pseudoaneurysm. Uterine artery embolization was performed with success. Uterine artery pseudoaneurysm should be listed as a differential diagnosis of pelvic mass after CS.

Entities:  

Mesh:

Year:  2010        PMID: 20492396     DOI: 10.1111/j.1447-0756.2009.01134.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  10 in total

1.  Diagnosing and treating postpartum uterine artery pseudoaneurysm.

Authors:  Kathlyn Parr; Anisha Hadimohd; Adrianne Browning; Jason Moss
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-02-01

2.  Uterine artery pseudoaneurysm: a rare cause of secondary postpartum haemorrhage following caesarean section.

Authors:  Papa Dasari; Dilip K Maurya; Mariano Mascarenhas
Journal:  BMJ Case Rep       Date:  2011-03-25

3.  Delayed postpartum abdominal bleeding caused by a spontaneous ruptured branch of the internal iliac artery and successfully treated by arterial embolisation.

Authors:  R M Ebbing; M N Baumgarten; G F A J B v Tilborg; P J H M Reuwer
Journal:  BMJ Case Rep       Date:  2015-06-08

4.  Modified sandwich embolization technique for postpartum hemorrhage caused by uterine artery pseudoaneurysm: a case series.

Authors:  Mimi Zhou; Tingwei Chen; Yongsen Li; Qianyan Tan; Huawei Shen; Duzhou Zheng; Shikuan Huang; Mingjin Cai
Journal:  Arch Gynecol Obstet       Date:  2020-09-10       Impact factor: 2.344

5.  Massive secondary postpartum hemorrhage with uterine artery pseudoaneurysm after cesarean section.

Authors:  Ahmet Ozgur Yeniel; Ahmet Mete Ergenoglu; Ali Akdemir; Elmin Eminov; Fuat Akercan; Nedim Karadadaş
Journal:  Case Rep Obstet Gynecol       Date:  2013-04-04

6.  Prior cesarean section is associated with increased preeclampsia risk in a subsequent pregnancy.

Authors:  Geum Joon Cho; Log Young Kim; Kyung-Jin Min; Ye Na Sung; Soon-Cheol Hong; Min-Jeong Oh; Hong-Seog Seo; Hai-Joong Kim
Journal:  BMC Pregnancy Childbirth       Date:  2015-02-13       Impact factor: 3.007

7.  Severe hydronephrosis secondary to uterine artery pseudoaneurysm in the early second trimester of pregnancy: A case report.

Authors:  Tsukuru Amano; Shinsuke Tokoro; Shunichiro Tsuji; Takashi Inoue; Fuminori Kimura; Takashi Murakami
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-25       Impact factor: 3.007

8.  Management of uterine artery pseudoaneurysm: advanced ultrasonography imaging and laparoscopic surgery as an alternative method to angio-computed tomography and transarterial embolization.

Authors:  Michał Ciebiera; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-10       Impact factor: 1.195

9.  Embolization of iatrogenic uterine pseudoaneurysm.

Authors:  Luca Boi; Sergio Savastano; Mario Beghetto; Jacopo Dall'Acqua; Giuseppe Mansi Montenegro
Journal:  Gynecol Minim Invasive Ther       Date:  2017-03-23

10.  Development of Vaginal Pseudoaneurysm 3 Years after Cesarean Section Possibly Induced by Anticoagulant and Antiplatelet Therapies.

Authors:  Yui Kinjo; Tadatsugu Kinjo; Keiko Mekaru; Hayase Nitta; Hitoshi Masamoto; Yoichi Aoki
Journal:  Case Rep Obstet Gynecol       Date:  2020-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.